Detalhe da pesquisa
1.
Nanoparticle delivery systems to combat drug resistance in ovarian cancer.
Nanomedicine
; 31: 102309, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32992019
2.
Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric Cancer.
Cancer Res Commun
; 4(6): 1399-1409, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38717153
3.
The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors.
Cancers (Basel)
; 16(8)2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672653
4.
Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target.
Med Oncol
; 40(7): 197, 2023 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37291277
5.
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer.
Res Sq
; 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38234761
6.
Peptide-based delivery of therapeutics in cancer treatment.
Mater Today Bio
; 14: 100248, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35434595
7.
Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer.
Mol Ther Nucleic Acids
; 30: 95-111, 2022 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36213692